Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
About Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
iCardio.ai is a Los Angeles-based company specializing in the development of machine learning and deep learning algorithms for ultrasound applications, with a specific focus on transthoracic echocardiography. The company leverages a proprietary database of over 200 million ultrasound images to enhance diagnostic accuracy and efficiency through artificial intelligence.
iCardio.ai’s mission is to automate the entire interpretation of echocardiograms, providing clinicians with automated, comprehensive imaging workflows and preliminary reporting tools. Their flagship product, EchoMeasure™, has received U.S. Food and Drug Administration (FDA) 510(k) clearance. Additionally, CardioVision™, an AI-based aortic stenosis detection tool, has earned FDA Breakthrough Device Designation, addressing unmet needs in cardiac diagnostics.
The company collaborates with leading ultrasound and healthcare technology companies, including GE Healthcare, UltraLinQ, SARC MedIQ, Butterfly Network, and Abbott Laboratories, to integrate its technology into existing platforms and expand the accessibility and utility of echocardiography AI. iCardio.ai is also incubating in partnership with Cedars-Sinai, a recognized research institution in cardiovascular medicine.
Focus Areas
Business Intelligence
| Key Investors | Cove Fund (investor in Cedars-Sinai Accelerator, which iCardio.ai joined) |
| Partnerships | GE Healthcare, UltraLinQ, SARC MedIQ, Abbott, Butterfly Network, deepc, Arkansas Heart Hospital, Conway Regional, Cedars-Sinai Accelerator, HeartX by HealthTech Arkansas and MedAxiom, NVIDIA Inception |
| Technology | Cloud-native, deep learning algorithms for ultrasound analysis, AI operating system (NVIDIA Clara Holoscan) |
| FDA Clearances | 2 (EchoMeasure™, CardioVision™ with Breakthrough Device Designation) cleared products (estimated) |
What Physicians Need to Know
For physicians, these AI-powered solutions offer significant advantages in improving diagnostic accuracy, efficiency, and consistency in cardiac care. iCardio.ai and Us2.ai can automate many manual measurements and provide comprehensive reports for echocardiograms, reducing sonographer fatigue and improving reproducibility. AccurKardia and HeartSciences Inc. are transforming ECG interpretation, enabling earlier detection of various cardiac conditions, including aortic stenosis, often in point-of-care settings without requiring specialized cardiac imaging. Echo IQ's solutions provide decision support for structural heart diseases like aortic stenosis and heart failure, aiming to identify severe cases more accurately and consistently. These technologies are designed to integrate into existing workflows, minimizing disruption and allowing clinicians to focus on critical thinking and patient outcomes.
Many of these companies emphasize seamless integration with existing hospital systems. Us2.ai, for example, plugs into existing PACS, CVIS, and reporting systems and is vendor-neutral across major OEM ultrasound devices. iCardio.ai has partnerships with GE Healthcare and other platforms to integrate its technology. AccurKardia's solutions are device-agnostic and offer API-based integrations and web-based reporting interfaces. HeartSciences Inc. is developing a cloud-based platform (MyoVista Insightsu2122) that is device-agnostic and can integrate with EHR systems. Echo IQ's platform is designed to integrate into existing ultrasound workflows.
Reviews & Opinions
Videos
News, demos, and interviews about Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ..
Videos load interactively. If none appear, search YouTube for Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ. →
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]